Post on 20-Aug-2019
Lampiran 6 C9
LEMBAR
HASIL PENILAIAN SEJAWAT SEBIDANG ATAlJ PEER REVIEW
KARYA ILMIAH : JlJRNAL ILMIAH
Judul Jurnal Ilmiah (Artikel)
Jumlah Penulis Status Pengusul Identitas Jurnal Ilmiah
Kategori Publikasi Jurnal Ilmiah (beri ✓pada kategori yang tepat)
Hasil Penilaian Peer Review
NO KOMPONEN YG DINILAI
a Kelengkapan unsur isi jurnal (I 0%)
b Ruang lingkup dan kedalaman pembahasan (30%)
Kecukupan dan kemutahiran C data/informasi dan metodologi
(30%)
d Kelengkapan unsur dan berkualitas terbitan/ jurnal (30%)
Nilai Total= (100%)
Nilai Pengusul = 40% x 40/4 = 4
':l_
:::::;
&
h
�
Prof. Dr. drg. OEDIJANI, M.S.
NIP I 9490209197901200 I
Unit Kerja : Fakultas Kedokteran UNDIP
* Dinilai oleh dua Reviewer secara terpisah
**Corel yang tidak perlu
***Nasional/terindeks di DOAJ CAB Copernicus
: A Single Common Assay for Robust and Rapid Fragile X Mental Retardation Syndrome Screening From Dried Blood Spots
: 5 orang : penulis pertama/ penulis ke 4/ penulis korespondensi **
: a. Nama Jurnal b. Nomor ISSNc. Volume nomor bulan tahund. Penerbite.DOJ artikel (Jika ada)
Frontiers in Genetics 1664-8021 Vol 9 Article 582, November 2018 Frontiers in Genetics 0
f. Alamat web Jurnalg.Terindeks di Scimagoir/Thomson Reuter ISi knowledge
https :/ /www. frontiers in .org/articles/ IO .3 3 89/fgen e.2018.00582/full
atau di .....
:§
Jurnal llmiah Internasional / internasional bereputasi * Jurnal Ilmiah Nasional Terakreditasi Jurnal llmiah Nasional/ Nasional terindeks di DOA.I CAB! COPERNICUS** Tidak Terakreditasi
Nilai Maksimal Jurnal llmiah
lnternasional/inter Nasional Nasional *** Nilai Akhir Yang
nasional bereputasi Terakreditasi
12\1 12.77 n Diperoleh
4 X 0.1 0 0 = 0.4 o)y
4 X 0.3 0 0 = 1.2 I> I
4 X 0.3 0 0 = 1.2 1, I
4 0.3 0 0 1.2 ' ) =
40 X 0.4 / 4 = 4 3 ... tf
Lampiran 6 C9
LEMBAR
HASIL PENILAIAN SEJAWAT SEBIDANG ATAU PEER REVIEW
KARY A ILMIAH : JURNAL ILMIAH
Judul Jurnal Ilmiah (Artikel)
Jumlah Penulis
Status Pengusul
Identitas Jurnal Ilmiah
Kategori Publikasi Jurnal Ilmiah
(beri ✓pada kategori yang tepat)
Hasil Penilaian Peer Review
NO KOMPONEN YG DINILAI
a Kelengkapan unsur isi jurnal (I 0%)
b Ruang lingkup dan kedalaman
pembahasan (30%)
Kecukupan dan kemutahiran
C data/informasi dan metodologi
(30%)
d Kelengkapan unsur dan berkualitas
terbitan/ jurnal (30%)
Nilai Total= (100%)
Nilai Pengusul = 40% x 40/4 = 4
,.
Semarang, ............................. .
NIP 1955051 I 198103 I 004
Unit Ke�ja : Fakultas Kedokteran UNDIP
* Dinilai oleh dua Reviewer secara terpisah
**Coret yang tidak perlu
***Nasional/terindeks di DOA.I CAB Copernicus
: A Single Common Assay for Robust and Rapid Fragile X Mental Retardation Syndrome
Screening From Dried Blood Spots
: 5 orang
: penulis pertama/ penulis ke 4/ penulis korespondensi **
: a. Nama Jurnal Frontiers in Genetics
b. Nomor ISSN 1664-8021
c. Volume nomor bulan tahun Vol 9 Article 582, November 2018
d. Penerbit Frontiers in Genetics
e.DOJ artikel (Jika ada)https://www.frontiersin.org/articles/10.3389/fg
f. Alamat web Jurnal ene.2018.00582/full
g.Terindeks di Scimagoir/ Thomson
Reuter ISi knowledge ataudi .. ... Sinta
:§ Jurnal Ilmiah Internasional / internasional bereputasi *
Jurnal Ilmiah Nasional Terakreditasi
Jurnal llmiah Nasional/ Nasional terindeks di DOA.I CAB! COPERNICUS** Tidak Terakreditasi
lnternasional/intern
asional bereputasi
rzil.4 X 10% = 0.4
4 X 30% = 1.2
4 X 30% = 1.2
4 X 30% = 1.2
40 X 40% I 4 = 4
Nilai Maksimal Jurnal Ilmiah
Nasional
Terakreditasi Nasional ***
rwl n
Nilai Akhir Yang
Diperoleh
°'�-
�z..
I, I
�<.
.3q . . .
26/4/2019 Scopus - Document details
https://www.scopus.com/record/display.uri?eid=2-s2.0-85063986916&origin=resultslist&sort=plf-f&src=s&sid=486ec69bae18f419dfee46637188d4… 1/6
Scopus
Document details
5 of 19
A single common assay for robust and rapid fragile X mental retardation syndrome screening from dried blood spots (Article) (Open Access)
, , , ,
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeKhoo Teck Puat – National University Children's Medical Institute, National University Health System, Singapore,
SingaporeDivision of Human Genetics, Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang,
Indonesia
AbstractBackground: FMR1 CGG trinucleotide repeat hyper-expansions are observed in 99% of individuals with fragile Xmental retardation syndrome (FXS). We evaluated the reliability of a rapid single-step gender-neutral molecularscreen for FXS when performed on DNA isolated from dried blood spots. Methods: DNA was extracted from driedblood spots of 151 individuals with intellectual disability or autism spectrum disorder , whose FMR1 repeatgenotypes are known. Dried blood spots were blinded prior to DNA extraction and analysis by triplet primed PCR (TP-PCR) and melt curve analysis (MCA). All expansion-positive and representative expansion-negative samples were alsogenotyped by fluorescent TP-PCR and capillary electrophoresis (CE) to confirm repeat expansion status. Results: Threemales and 12 females were classified as expanded by TP-PCR MCA, and were subsequently sized by fluorescent TP-PCR CE. Two males and four females carried premutations, while one male and eight females carried full mutations.All 19 non-expanded samples that were sized were confirmed as carrying only normal alleles. Replicate analysis ofrepresentative expansion-positive samples yielded reproducible melt peak profiles. TP-PCR MCA classifications werecompletely concordant with FMR1 CGG repeat genotypes. Conclusion: TP-PCR MCA of dried blood spot DNAaccurately and reliably identifies presence/absence of FMR1 CGG repeat expansions in both genders simultaneously.This strategy may be suitable for rapid high-throughput first-tier screening for fragile X syndrome . Copyright© 2018 Tan, Lian, Faradz, Winarni and Chong. This is an open-access article distributed under the terms of theCreative Commons Attribution License (CC BY).
Author keywordsDried blood spot FMR1 Fragile X syndrome Melt curve analysis (MCA) Trinucleotide repeat
Triplet-primed PCR (TP-PCR)
Funding details
Funding sponsor Funding number Acronym
University of the Punjab 176-13/UN7.5.1/PG/2016 PU
Temple University Health System NUHSRO/2015/056/STB/BBP FY15/01 TUHS
Funding textThis work was funded in part by a PUPT Kemenristek Dikti Grant (No. 176-13/UN7.5.1/PG/2016) to TW and a NationalUniversity Health System grant (NUHSRO/2015/056/STB/BBP FY15/01) to SC.
◅ Back to results ◅ Previous ▻Next
Export Download Print E-mail Save to PDF ⋆ Add to List ▻More...
View at Publisher
Open AccessFrontiers in GeneticsVolume 9, 2018, Article number 582
Tan, V.J.a Lian, M.b Faradz, S.M.H.c Winarni, T.I. Chong, S.S.a,b,d
a
b
c
View additional affiliations
View references (29)
ISSN: 16648021Source Type: Journal
DOI: 10.3389/fgene.2018.00582Document Type: Article
PlumX MetricsUsage, Captures, Mentions,Social Media and Citationsbeyond Scopus.
Metrics
0 Citations in Scopus
0 Field-Weighted
Citation Impact
Cited by 0 documents
Inform me when this documentis cited in Scopus:
Related documents
, ,
(2015) Expert Reviews inMolecular Medicine
, ,
(2014) Journal of MolecularDiagnostics
, , (2018) Annals of Clinical andLaboratory Science
Find more related documents inScopus based on:
Set citation alert ▻
▻Set citation feed
Simplified strategy for rapid first-line screening of fragile Xsyndrome: Closed-tube triplet-primed PCR and amplicon meltpeak analysis
Rajan-Babu, I.-S. Law, H.-Y.Yoon, C.-S.
Extra alleles in FMR1 triple-primed PCR: Artifact, aneuploidy,or somatic mosaicism
Wakeling, E.N. Nahhas, F.A.Feldman, G.L.
A technical note: Validation of ascreening method for dynamicmutations in the FMR1 gene
Škrlec, I. Barišić, K. Wagner, J.
View all related documents basedon references
▻Authors ▻Keywords
26/4/2019 Scopus - Document details
https://www.scopus.com/record/display.uri?eid=2-s2.0-85063986916&origin=resultslist&sort=plf-f&src=s&sid=486ec69bae18f419dfee46637188d4… 2/6
References (29)
Abrams, L., Cronister, A., Brown, W.T., Tassone, F., Sherman, S.L., Finucane, B., Rosell, A.M.-., (...), Berry-Kravis, E.
(2012) Pediatrics, 130 (6), pp. 1126-1135. .
doi: 10.1542/peds.2012-0693
(2017) Obstetrics and Gynecology, 129 (3), pp. e41-e55. .
doi: 10.1097/AOG.0000000000001952
Bailey Jr., D.B.
(2004) Mental Retardation and Developmental Disabilities Research Reviews, 10 (1), pp. 3-10. . doi: 10.1002/mrdd.20002
Biancalana, V., Glaeser, D., McQuaid, S., Steinbach, P.
(Open Access) (2015) European Journal of Human Genetics, 23 (4), pp. 417-425. .
doi: 10.1038/ejhg.2014.185
Castagnola, S., Bardoni, B., Maurin, T.
(Open Access) (2017) Frontiers in Synaptic Neuroscience, 9 (NOV), art. no. 15. .
doi: 10.3389/fnsyn.2017.00015
Chow, J.C., Chen, D.-J., Lin, C.-N., Chiu, C.Y., Huang, C.-B., Chiu, P.-C., Lin, C.-H., (...), Tzeng, C.-C.
(2003) Journal of the Formosan Medical Association, 102 (1), pp. 12-16. .
Fernandez-Carvajal, I., Posadas, B.L., Pan, R., Raske, C., Hagerman, P.J., Tassone, F.
(2009) Journal of Molecular Diagnostics, 11 (4), pp. 306-310. .
doi: 10.2353/jmoldx.2009.080174
Original language: English Publisher: Frontiers Media S.A.
▻View in search results format
All Export Print E-mail Save to PDF Create bibliography
1
Newborn, carrier, and early childhood screening recommendations for fragile X
Cited 26 timeshttp://pediatrics.aappublications.org/content/130/6/1126.full.pdf+html
View at Publisher
2 Carrier screening for genetic conditions
Cited 42 timeshttp://journals.lww.com/greenjournal
View at Publisher
3
Newborn Screening for Fragile X Syndrome
Cited 53 times
View at Publisher
4
EMQN best practice guidelines for the molecular genetic testing and reporting offragile X syndrome and other fragile X-associated disorders
Cited 33 timeshttp://www.nature.com/ejhg/index.html
View at Publisher
5
The search for an effective therapy to treat Fragile X Syndrome: Dream or reality?
Cited 12 timeshttps://www.frontiersin.org/articles/10.3389/fnsyn.2017.00015/full
View at Publisher
6
Feasibility of blood spot PCR in large-scale screening of fragile X syndrome inSouthern Taiwan
Cited 13 times
7
Expansion of an FMR1 grey-zone allele to a full mutation in two generations
Cited 88 timeshttp://jmd.amjpathol.org/cgi/reprint/11/4/306
View at Publisher
26/4/2019 Scopus - Document details
https://www.scopus.com/record/display.uri?eid=2-s2.0-85063986916&origin=resultslist&sort=plf-f&src=s&sid=486ec69bae18f419dfee46637188d4… 3/6
Fu, Y.-H., Kuhl, D.P.A., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkert, A.J.M.H., (...), Caskey, C.T.
(1991) Cell, 67 (6), pp. 1047-1058. . doi: 10.1016/0092-8674(91)90283-5
Hagerman, R.J., Berry-Kravis, E., Hazlett, H.C., Bailey, D.B., Moine, H., Kooy, R.F., Tassone,F., (...), Hagerman, P.J.
(2017) Nature reviews. Disease primers, 3, p. 17065. . doi: 10.1038/nrdp.2017.65
Hoyos, L.R., Thakur, M.
(2017) Journal of Assisted Reproduction and Genetics, 34 (3), pp. 315-323. .
doi: 10.1007/s10815-016-0854-6
Jacquemont, S., Hagerman, R.J., Leehey, M.A., Hall, D.A., Levine, R.A., Brunberg, J.A., Zhang,L., (...), Hagerman, P.J.
(2004) Journal of the American Medical Association, 291 (4), pp. 460-469. . doi: 10.1001/jama.291.4.460
Kronquist, K.E., Sherman, S.L., Spector, E.B.
(Open Access) (2008) Genetics in Medicine, 10 (11), pp. 845-847. .
doi: 10.1097/GIM.0b013e31818c2606
Ligsay, A., Hagerman, R., Berry-Kravis, E.
(2017) Fragile X Syndrome: From Genetics to Targeted Treatment, pp. 401-418. .
ISBN: 978-012804507-7; 978-012804461-2 doi: 10.1016/B978-0-12-804461-2.00019-6
McLennan, Y., Polussa, J., Tassone, F., Hagerman, R.
(2011) Current Genomics, 12 (3), pp. 216-224. .
doi: 10.2174/138920211795677886
8
Variation of the CGG repeat at the fragile X site results in genetic instability:Resolution of the Sherman paradox
Cited 1561 times
View at Publisher
9
Fragile X syndrome
Cited 30 times
View at Publisher
10
Fragile X premutation in women: recognizing the health challenges beyond primaryovarian insufficiency
Cited 8 timeswww.wkap.nl/journalhome.htm/1058-0468
View at Publisher
11
Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a PremutationCarrier Population
Cited 422 times
View at Publisher
12
Clinical significance of tri-nucleotide repeats in Fragile X testing: A clarification ofAmerican College of Medical Genetics guidelines
Cited 47 timeshttp://www.nature.com/gim/index.html
View at Publisher
13
Overview of Targeted Double-Blind, Placebo-Controlled Clinical Trials in Fragile XSyndrome
Cited 2 timeshttps://www.sciencedirect.com/book/9780128044612
View at Publisher
14
Fragile X syndrome
Cited 89 timeshttp://www.benthamdirect.org/pages/all_b_bypublication.php
View at Publisher
26/4/2019 Scopus - Document details
https://www.scopus.com/record/display.uri?eid=2-s2.0-85063986916&origin=resultslist&sort=plf-f&src=s&sid=486ec69bae18f419dfee46637188d4… 4/6
Monaghan, K.G., Lyon, E., Spector, E.B.
(Open Access) (2013) Genetics in Medicine, 15 (7), pp. 575-586. . doi: 10.1038/gim.2013.61
Nolin, S.L., Brown, W.T., Glicksman, A., Houck Jr., G.E., Gargano, A.D., Sullivan, A., Biancalana,V., (...), Sherman, S.L.
(Open Access) (2003) American Journal of Human Genetics, 72 (2), pp. 454-464. .
doi: 10.1086/367713
Nolin, S.L., Glicksman, A., Ding, X., Ersalesi, N., Brown, W.T., Sherman, S.L., Dobkin, C.
(Open Access) (2011) Prenatal Diagnosis, 31 (10), pp. 925-931. . doi: 10.1002/pd.2815
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S.T., Oostra, B.A., Caskey, C.T., Nelson, D.L.
(1991) Cell, 66 (4), pp. 817-822. . doi: 10.1016/0092-8674(91)90125-I
Rajan-Babu, I.-S., Law, H.-Y., Yoon, C.-S., Lee, C.G., Chong, S.S.
(Open Access) (2015) Expert Reviews in Molecular Medicine, 17, art. no. e7. .
doi: 10.1017/erm.2015.5
Rajan-Babu, I.-S., Lian, M., Tran, A.H., Dang, T.T., Le, H.T.-M., Thanh, M.N., Lee, C.G., (...), Chong, S.S.
(2016) Journal of Molecular Diagnostics, 18 (5), pp. 719-730. .
doi: 10.1016/j.jmoldx.2016.05.002
Rodriguez-Revenga, L., Madrigal, I., Pagonabarraga, J., Xunclà, M., Badenas, C., Kulisevsky, J., Gomez,B., (...), Milà, M.
(Open Access) (2009) European Journal of Human Genetics, 17 (10), pp. 1359-1362. . doi: 10.1038/ejhg.2009.51
15
ACMG standards and guidelines for fragile X testing: A revision to the disease-specificsupplements to the standards and guidelines for Clinical Genetics Laboratories of theAmerican College of Medical Genetics and Genomics
Cited 58 times
View at Publisher
16
Expansion of the fragile X CGG repeat in females with premutation or intermediatealleles
Cited 259 timeshttp://www.elsevier.com/wps/find/journaldescription.cws_home/713561/description#description
View at Publisher
17
Fragile X analysis of 1112 prenatal samples from 1991 to 2010
Cited 64 times
View at Publisher
18
Absence of expression of the FMR-1 gene in fragile X syndrome
Cited 1034 times
View at Publisher
19
Simplified strategy for rapid first-line screening of fragile X syndrome: Closed-tubetriplet-primed PCR and amplicon melt peak analysis
Cited 10 timeshttp://journals.cambridge.org
View at Publisher
20
Defining the Performance Parameters of a Rapid Screening Tool for FMR1 CGG-Repeat Expansions Based on Direct Triplet-Primed PCR and Melt Curve Analysis
Cited 2 timeshttp://www.sciencedirect.com/science/journal/15251578
View at Publisher
21
Penetrance of FMR1 premutation associated pathologies in fragile X syndromefamilies
Cited 173 times
View at Publisher
26/4/2019 Scopus - Document details
https://www.scopus.com/record/display.uri?eid=2-s2.0-85063986916&origin=resultslist&sort=plf-f&src=s&sid=486ec69bae18f419dfee46637188d4… 5/6
Sutcliffe, J.S., Nelson, D.L., Zhang, F., Pieretti, M., Caskey, C.T., Saxe, D., Warren, S.T.
(1992) Human Molecular Genetics, 1 (6), pp. 397-400. . doi: 10.1093/hmg/1.6.397
Tassone, F.
(Open Access) (2014) JAMA Neurology, 71 (3), pp. 355-359. .
doi: 10.1001/jamaneurol.2013.4808
Tassone, F., Iong, K.P., Tong, T.-H., Lo, J., Gane, L.W., Berry-Kravis, E., Nguyen, D., (...), Hagerman, R.J.
(Open Access) (2012) Genome Medicine, 4 (12), art. no. 100. .
doi: 10.1186/gm401
Tassone, F., Pan, R., Amiri, K., Taylor, A.K., Hagerman, P.J.
(2008) Journal of Molecular Diagnostics, 10 (1), pp. 43-49. .
doi: 10.2353/jmoldx.2008.070073
Teo, C.R.L., Law, H.-Y., Lee, C.G., Chong, S.S.
(Open Access) (2012) Clinical Chemistry, 58 (3), pp. 568-579. .
doi: 10.1373/clinchem.2011.174615
Tzeng, C.-C., Lin, S.-J., Chen, Y.-J., Kuo, P.-L., Jong, Y.-J., Tsai, L.-P., Chen, R.M.
(2001) Diagnostic Molecular Pathology, 10 (1), pp. 34-40. . doi: 10.1097/00019606-200103000-00006
Verkerk, A.J.M.H., Pieretti, M., Sutcliffe, J.S., Fu, Y.-H., Kuhl, D.P.A., Pizzuti, A., Reiner, O., (...), Warran, S.T.
(1991) Cell, 65 (5), pp. 905-914. . doi: 10.1016/0092-8674(91)90397-H
22
DNA methylation represses FMR-1 transcription in fragile x syndrome
Cited 491 times
View at Publisher
23
Newborn screening for fragile X syndrome
Cited 28 timeshttp://archneur.jamanetwork.com/article.aspx?articleid=1812404
View at Publisher
24
FMR1 CGG allele size and prevalence ascertained through newborn screening in theUnited States
Cited 141 timeshttp://genomemedicine.com/content/4/12/100
View at Publisher
25
A rapid polymerase chain reaction-based screening method for identification of allexpanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations
Cited 236 timeshttp://www.sciencedirect.com/science/journal/15251578
View at Publisher
26
Screening for CGG repeat expansion in the FMR1 gene by melting curve analysis ofcombined 5′ and 3′ direct triplet-primed PCRs
Cited 18 timeshttp://www.clinchem.org/content/58/3/568.full.pdf+html
View at Publisher
27
An effective strategy of using molecular testing to screen mentally retarded individualsfor fragile X syndrome
Cited 11 times
View at Publisher
28
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpointcluster region exhibiting length variation in fragile X syndrome
Cited 2420 times
View at Publisher
26/4/2019 Scopus - Document details
https://www.scopus.com/record/display.uri?eid=2-s2.0-85063986916&origin=resultslist&sort=plf-f&src=s&sid=486ec69bae18f419dfee46637188d4… 6/6
5 of 19
Winarni, T.I., Utari, A., Mundhofir, F.E.P., Tong, T., Durbin-Johnson, B., Faradz, S.M.H., Tassone, F.
(2012) Genetic Testing and Molecular Biomarkers, 16 (3), pp. 162-166. . doi: 10.1089/gtmb.2011.0089
Chong, S.S.; Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore,Singapore, Singapore; email: © Copyright 2019 Elsevier B.V., All rights reserved.
29
Identification of expanded alleles of the FMR1 gene among high-risk population inindonesia by using blood spot screening
Cited 6 times
View at Publisher
paecs@nus.edu.sg
◅ Back to results ◅ Previous ▻Next Top of page
About Scopus
What is Scopus
Content coverage
Scopus blog
Scopus API
Privacy matters
Language
⽇本語に切り替える切换到简体中文
切換到繁體中文
Русский язык
Customer Service
Help
Contact us
Copyright © 2019 . All rights reserved. Scopus® is a registered trademark of Elsevier B.V. We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the
.
↗Terms and conditions ↗Privacy policy
↗Elsevier B.V
use of cookies
26/4/2019 Scopus - Frontiers in Genetics
https://www.scopus.com/sourceid/21100236803?origin=recordpage 1/1
Scopus
Source details
Open Access
Frontiers in Genetics
Scopus coverage years: from 2010 to 2018Publisher: Frontiers Media S.A.ISSN: 1664-8021Subject area: Medicine: Genetics (clinical) Biochemistry, Genetics and Molecular Biology: Genetics
Biochemistry, Genetics and Molecular Biology: Molecular Medicine
View all documents ▻ Set document alert Journal Homepage
↗Visit Scopus Journal Metrics
CiteScore 2017
3.78
SJR 2017
2.274
SNIP 2017
1.032
CiteScore CiteScore rank & trend Scopus content coverage
Calculated using data from 30 April, 2018CiteScore
*CiteScore includes all available document types
3.78 =
Citation Count 2017
Documents 2014 -2016*
=
Metrics displaying this icon are compiled according to , a collaboration between
industry and academia.
2017
▻3.973 Citations
▻1.050 Documents
▻View CiteScore methodology ▻CiteScore FAQ
Last updated on 11 April, 2019CiteScoreTracker 2018
3.59 = Citation Count 2018
Documents 2015 - 2017 =
Updated monthly
▻2.941 Citations to date
▻819 Documents to date
↗ Snowball Metrics
CiteScore rank
Category Rank Percentile
Medicine #18/89 80th
Biochemistry,Genetics andMolecularBiology
#64/310 79th
Genetics(clinical)
Genetics
▻View CiteScore trends
🔗Add CiteScore to your site
About Scopus
What is Scopus
Content coverage
Scopus blog
Scopus API
Privacy matters
Language
⽇本語に切り替える切换到简体中文
切換到繁體中文
Русский язык
Customer Service
Help
Contact us
Copyright © 2019 . All rights reserved. Scopus® is a registered trademark of Elsevier B.V. We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the
.
↗Terms and conditions ↗Privacy policy
↗Elsevier B.V
use of cookies